Status:
TERMINATED
Breast Cancer Self-Efficacy Scale for Partners
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Indiana Clinical and Translational Sciences Institute
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The concept of self-efficacy is a major predictor of physical, psychological, social and overall quality of life (QoL) among breast cancer survivors (BCS). Because survivor and partner outcomes are of...
Detailed Description
Compared to partners of healthy women, partners of breast cancer survivors (BCS) are at an increased risk of affective disorders, including depression and anxiety;1 are more likely to report antidepre...
Eligibility Criteria
Inclusion
- Identifies as a partner, significant other, or spouse of an individual diagnosed with non-metastatic breast cancer
- Is 18 years of age or over
- Is able and willing to attend a focus group, individual interview, or complete an online survey
- Is able to access the internet
- Is able to carry on normal everyday conversation
Exclusion
- · Partners who have separated or divorced since survivors' diagnosis
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05228210
Start Date
September 1 2019
End Date
March 1 2022
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrea A Cohee
Indianapolis, Indiana, United States, 46202